OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanomedicines Targeting Glioma Stem Cells
Arjun Sabu, Te‐I Liu, Siew Suan Ng, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 1, pp. 158-181
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Engineering nanomaterials for glioblastoma nanovaccination
Fatima Hameedat, Bárbara B. Mendes, João Conniot, et al.
Nature Reviews Materials (2024) Vol. 9, Iss. 9, pp. 628-642
Closed Access | Times Cited: 12

Signaling pathways governing glioma cancer stem cells behavior
Ava Nasrolahi, Shirin Azizidoost, Klaudia Radoszkiewicz, et al.
Cellular Signalling (2022) Vol. 101, pp. 110493-110493
Closed Access | Times Cited: 29

Glioma stem cell‐derived exosomes induce the transformation of astrocytes via the miR‐3065‐5p/DLG2 signaling axis
Haoran Li, Jianjun Zhu, Xinglei Liu, et al.
Glia (2024) Vol. 72, Iss. 5, pp. 857-871
Closed Access | Times Cited: 6

Fusion between Glioma Stem Cells and Mesenchymal Stem Cells Promotes Malignant Progression in 3D-Bioprinted Models
Xingliang Dai, Yuxuan Shao, Xuefeng Tian, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 31, pp. 35344-35356
Closed Access | Times Cited: 24

Menthol-modified paclitaxel multifunctional cationic liposomes cross the blood-brain barrier and target glioma stem cells for treatment of glioblastoma
Jia-yu Cai, Yang Liu, Lu Zhang, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105387-105387
Closed Access | Times Cited: 5

Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology
Baoqin Song, Xiu Wang, Lijing Qin, et al.
Pharmacological Research (2024) Vol. 206, pp. 107308-107308
Open Access | Times Cited: 5

NIR-II photo- and sono-responsive hyaluronic acid-capped nanozymes for glioblastoma-targeting theranostics
Huanran Qu, Yuanyuan Zhang, Minghao Chen, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141737-141737
Closed Access

A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment
Xing Yang, Feroza Yasinjan, Mei Yang, et al.
Nano Today (2023) Vol. 52, pp. 101961-101961
Closed Access | Times Cited: 12

Sniping Cancer Stem Cells with Nanomaterials
Wen-Da Wang, Yanyu Guo, Zhonglu Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23262-23298
Closed Access | Times Cited: 12

Advances in research on immune escape mechanism of glioma
Xu Guo, Gang Wang
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 7, pp. 1709-1720
Open Access | Times Cited: 11

A Novel Patient‐Personalized Nanovector Based on Homotypic Recognition and Magnetic Hyperthermia for an Efficient Treatment of Glioblastoma Multiforme
Daniele De Pasquale, Carlotta Pucci, Andrea Desii, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Open Access | Times Cited: 9

Glutamine Metabolism Heterogeneity in Glioblastoma Unveils an Innovative Combination Therapy Strategy
Huangde Fu, Shengtian Wu, Hechun Shen, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 2
Closed Access | Times Cited: 3

Efficacy of a novel glioma therapy based on ferroptosis induced by layered double hydroxide loaded with simvastatin
Wei Peng, Yufeng Qian, Xuchen Qi
Environmental Research (2023) Vol. 238, pp. 117112-117112
Closed Access | Times Cited: 6

The Present and Future of Optic Pathway Glioma Therapy
Simone Dal Bello, Deborah Martinuzzi, Yan Tereshko, et al.
Cells (2023) Vol. 12, Iss. 19, pp. 2380-2380
Open Access | Times Cited: 4

The Impact of A3AR Antagonism on the Differential Expression of Chemoresistance-Related Genes in Glioblastoma Stem-like Cells
Liuba Peñate, Diego Carrillo-Beltrán, Carlos Spichiger, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 579-579
Open Access | Times Cited: 1

GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin
Haiyang Wang, Ding Wang, Yong-Feng Shen, et al.
Cancer Gene Therapy (2022)
Closed Access | Times Cited: 7

Rac GTPase activating protein 1 promotes the glioma growth by regulating the expression of MCM3
Bo Jia, Yuran Jiang, Huan Yu, et al.
Translational Oncology (2023) Vol. 37, pp. 101756-101756
Open Access | Times Cited: 2

Biological role of long non-coding RNA KCNQ1OT1 in cancer progression
Kai Zhan, Huafeng Pan, Zhou Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115876-115876
Open Access | Times Cited: 2

CircVCAN promotes glioma progression through the miR‐488‐3p/MEF2C‐JAGGED1 axis
Shude Yang, Shuo Gao, Zhiqiang Dong
Environmental Toxicology (2024) Vol. 39, Iss. 9, pp. 4417-4430
Closed Access

PRMT1 promotes radiotherapy resistance in glioma stem cells by inhibiting ferroptosis
Hong Li, Xiaoyan Qi, Lijun He, et al.
Japanese Journal of Radiology (2024)
Closed Access

Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of Glioma
Ying Lu, Zhouyu Wang, Danmeng Zhang, et al.
Cellular and Molecular Neurobiology (2024) Vol. 45, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top